معرفی
Professor Juliet Gray is a leading academic in the field of paediatric oncology at the University of Southampton, affiliated with the Department of Paediatric Oncology at Southampton Children's Hospital and the Centre for Cancer Immunology. Her research focuses on neuroblastoma and cancer immunotherapy, particularly the development of novel antibody therapies and international clinical trials for children with neuroblastoma.
- Key affiliations: Institute for Life Sciences, Centre for Cancer Immunology, Antibody and Vaccine Group, Institute of Developmental Sciences
Her research interests include:
- Translational immunotherapy research for neuroblastoma
- FC gamma receptor polymorphism analysis
- Pre-clinical modeling of neuroblastoma
- Epigenetic therapies combined with monoclonal antibodies
- Development of 3D tumor models for osteosarcoma and neuroblastoma
Recent publications (2024-2025) demonstrate expertise in:
- Antibody engineering for enhanced effector functions
- Clinical trials for paediatric cancers
- Epigenetic modulation in high-risk neuroblastoma
- Exercise physiology effects on immunotherapy efficacy
- Molecular radiotherapy optimization
Scientific awards include:
- CRN Wessex Outstanding Principal Investigator (2018)
- Solving Kids Cancer Research Hero (2022)
Professor Gray holds leadership roles in:
- SIOPEN European Neuroblastoma Research Network
- NCRI Childhood Cancer Leukaemia Clinical Study Group
- Scientific Advisory Boards for Solving Kids Cancer and Neuroblastoma Australia
- CRUK Protocol Safety Review Board
She actively contributes to:
- International clinical trials (MINIVAN, ITCC-SIOPEN BEACON)
- Grants from Cancer Research UK, Children's Cancer & Leukaemia Group, and Neuroblastoma UK
- Multidisciplinary collaborations with immunologists, geneticists, and clinical teams
۰مقاله منتشرشده
